Breast Cancer with Brca2 Mutation
📧 Sign up to get email alerts when something new happens for Breast Cancer with Brca2 Mutation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer [Phase 1]
This clinical trial update describes a Phase Ib study evaluating Axatilimab in combination with Olaparib for BRCA1/2- and PALB2-associated m…